These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28657829)

  • 1. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis.
    Ozen A; Comrie WA; Ardy RC; Domínguez Conde C; Dalgic B; Beser ÖF; Morawski AR; Karakoc-Aydiner E; Tutar E; Baris S; Ozcay F; Serwas NK; Zhang Y; Matthews HF; Pittaluga S; Folio LR; Unlusoy Aksu A; McElwee JJ; Krolo A; Kiykim A; Baris Z; Gulsan M; Ogulur I; Snapper SB; Houwen RHJ; Leavis HL; Ertem D; Kain R; Sari S; Erkan T; Su HC; Boztug K; Lenardo MJ
    N Engl J Med; 2017 Jul; 377(1):52-61. PubMed ID: 28657829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease.
    Ozen A
    Immunol Rev; 2019 Jan; 287(1):20-32. PubMed ID: 30565236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease.
    Ozen A; Kasap N; Vujkovic-Cvijin I; Apps R; Cheung F; Karakoc-Aydiner E; Akkelle B; Sari S; Tutar E; Ozcay F; Uygun DK; Islek A; Akgun G; Selcuk M; Sezer OB; Zhang Y; Kutluk G; Topal E; Sayar E; Celikel C; Houwen RHJ; Bingol A; Ogulur I; Eltan SB; Snow AL; Lake C; Fantoni G; Alba C; Sellers B; Chauvin SD; Dalgard CL; Harari O; Ni YG; Wang MD; Devalaraja-Narashimha K; Subramanian P; Ergelen R; Artan R; Guner SN; Dalgic B; Tsang J; Belkaid Y; Ertem D; Baris S; Lenardo MJ
    Nat Immunol; 2021 Feb; 22(2):128-139. PubMed ID: 33398182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency.
    Kurolap A; Eshach Adiv O; Hershkovitz T; Tabib A; Karbian N; Paperna T; Mory A; Vachyan A; Slijper N; Steinberg R; Zohar Y; Mevorach D; Baris Feldman H
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):325-333. PubMed ID: 30418410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CD55 in Eculizumab-Responsive Protein-Losing Enteropathy.
    Kurolap A; Eshach-Adiv O; Hershkovitz T; Paperna T; Mory A; Oz-Levi D; Zohar Y; Mandel H; Chezar J; Azoulay D; Peleg S; Half EE; Yahalom V; Finkel L; Weissbrod O; Geiger D; Tabib A; Shaoul R; Magen D; Bonstein L; Mevorach D; Baris HN
    N Engl J Med; 2017 Jul; 377(1):87-89. PubMed ID: 28657861
    [No Abstract]   [Full Text] [Related]  

  • 6. Eculizumab-Responsive Adult Onset Protein Losing Enteropathy, Caused by Germline CD55-Deficiency and Complicated by Aggressive Angiosarcoma.
    Hagin D; Lahav D; Freund T; Shamai S; Brazowski E; Fishman S; Kurolap A; Baris Feldman H; Shohat M; Salomon O
    J Clin Immunol; 2021 Feb; 41(2):477-481. PubMed ID: 33215321
    [No Abstract]   [Full Text] [Related]  

  • 7. Beyond the Role of CD55 as a Complement Component.
    Dho SH; Lim JC; Kim LK
    Immune Netw; 2018 Feb; 18(1):e11. PubMed ID: 29503741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and Genotype of a Cohort of Chinese Children with Early-Onset Protein-Losing Enteropathy.
    Ye Z; Huang Y; Wang Y; Lu J; Wu J; Yu Z
    J Pediatr; 2019 May; 208():38-42.e3. PubMed ID: 30853196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the role of
    Kurolap A; Eshach-Adiv O; Gonzaga-Jauregui C; Dolnikov K; Mory A; Paperna T; Hershkovitz T; Overton JD; Kaplan M; Glaser F; Zohar Y; Shuldiner AR; Berger G; Baris HN
    J Med Genet; 2018 Nov; 55(11):779-784. PubMed ID: 29875123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CD55 Mutation Associated With Severe Small Bowel Ulceration Mimicking Inflammatory Bowel Disease in a Pair of Siblings.
    Chongsrisawat V; Suratannon N; Chatchatee P; Ittiwut R; Ittiwut C; Weerapakorn W; Theamboonlers A; Rohlfs M; Klein C; Kotlarz D; Suphapeetiporn K
    Inflamm Bowel Dis; 2022 Sep; 28(9):1458-1461. PubMed ID: 35134932
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement and the prothrombotic state.
    Schmidt CQ; Schrezenmeier H; Kavanagh D
    Blood; 2022 Mar; 139(13):1954-1972. PubMed ID: 34415298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protein losing enteropathy (PLE) detected by Tc99m-labelled human serum albumin abdominal scintigraphy--case report].
    Hubalewska-Hoła A; Sowa-Staszczak A; Szczerbiński T; Lis G; Huszno B; Szybiński Z
    Przegl Lek; 2003; 60(9):606-8. PubMed ID: 15065343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade.
    Pérez-Alós L; Bayarri-Olmos R; Skjoedt MO; Garred P
    FASEB J; 2019 Nov; 33(11):12723-12734. PubMed ID: 31469600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel
    Gorukmez O; Gorukmez O; Demiroren K
    Fetal Pediatr Pathol; 2019 Dec; 38(6):534-537. PubMed ID: 31215290
    [No Abstract]   [Full Text] [Related]  

  • 15. Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.
    Li Y; Johnson JB; Parks GD
    Virology; 2016 Oct; 497():305-313. PubMed ID: 27505156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.
    Leaderer D; Cashman SM; Kumar-Singh R
    J Gene Med; 2015; 17(6-7):101-15. PubMed ID: 25917932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations.
    Stephen J; Vilboux T; Haberman Y; Pri-Chen H; Pode-Shakked B; Mazaheri S; Marek-Yagel D; Barel O; Di Segni A; Eyal E; Hout-Siloni G; Lahad A; Shalem T; Rechavi G; Malicdan MC; Weiss B; Gahl WA; Anikster Y
    Eur J Hum Genet; 2016 Aug; 24(9):1268-73. PubMed ID: 26883093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
    J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital hepatic fibrosis combined with protein-losing enteropathy and recurrent thrombosis.
    Pedersen PS; Tygstrup I
    Acta Paediatr Scand; 1980 Jul; 69(4):571-4. PubMed ID: 7446108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.